# US Eubiotics Market > US Eubiotics Market Size, Share, Industry Trend & Analysis Research Report By Form (Liquid, Dry), By Type (Prebiotics, Probiotics, Others), By Function (General Health & Wellness, Immunity, Gut & Digestive Health, Others) andBy Livestock (Aquatic, Poultry, Ruminants, Swine, Others)- Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.62% - **2024:** $ 1.05 Billion - **2025:** $ 1.13 Billion - **2035:** $ 2.12 Billion - **Key Players:** BASF SE (DE), DuPont de Nemours Inc (US), Chr. Hansen Holding A/S (DK), Evonik Industries AG (DE), Kemin Industries Inc (US), Novozymes A/S (DK), Lallemand Inc (CA), Alltech Inc (US), BioCare Copenhagen A/S (DK) **Report ID:** MRFR/Agri/12715-HCR · **Pages:** 128 · **Author:** Snehal Singh & Pradeep Nandi · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-eubiotics-market-14242 --- ## Market Summary ## **US Eubiotics Market Overview** US Eubiotics Market Size was estimated at 650 (USD Million) in 2023. The US Eubiotics Market Industry is expected to grow from 698.7(USD Million) in 2024 to 1,528.8 (USD Million) by 2035. The US Eubiotics Market CAGR (growth rate) is expected to be around 7.378% during the forecast period (2025 - 2035). Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Key US Eubiotics Market Trends Highlighted** The US Eubiotics Market is experiencing significant shifts driven by increased consumer awareness regarding gut health and the demand for natural and organic products. Many consumers are looking for alternatives to conventional additives and antibiotics in both human and animal nutrition, leading to the rise of eubiotics, which are seen as a natural means to promote health and well-being. Moreover, regulatory support from health organizations and government initiatives aimed at promoting safer and more effective alternatives in food production further fuels the growth of eubiotics in the United States. The ongoing trend of clean label products reflects a growing consumer preference for transparency in ingredient sourcing.As people become more informed about the ingredients in their food and the impact of these ingredients on health, manufacturers are increasingly incorporating eubiotics to align with these expectations. The integration of eubiotics in livestock feeds to enhance animal performance and ensure food safety is another trend gaining traction. Opportunities in this market remain ripe, particularly as research into the health benefits of eubiotics continues to expand. There is an emerging interest in customizing eubiotic formulations based on specific health needs, whether for humans or for livestock. This customization could result in personalized nutrition solutions that cater to diverse consumer segments.Furthermore, as the eubiotics market grows, there is potential for innovation in production methods and formulations that may enhance the effectiveness of these products and meet stringent quality standards set by regulatory bodies. All these factors create a dynamic environment for the US Eubiotics Market, paving the way for continued growth and development. **US Eubiotics Market Drivers** **Growing Awareness of Gut Health Among Consumers** In the US, there is a significant trend toward health and wellness, with increasing consumer awareness about the importance of gut health for overall wellbeing. According to the International Food Information Council, 76% of people actively look for information about food and nutrition, with many consumers acknowledging the role of probiotics and prebiotics in maintaining a balanced gut microbiome. This heightened awareness is fostering demand for eubiotic products, which are designed to improve gut health.Organizations such as the American Gastroenterological Association are promoting research and education around gut health, which may further drive the US Eubiotics Market Industry. As consumers seek out products that can enhance digestive health, the market for eubiotics is expected to grow significantly over the coming years, with an increasing variety of products being introduced in the marketplace. **Rising Incidence of Digestive Disorders** The increasing prevalence of digestive disorders in the US is another major driver prompting the growth of the US Eubiotics Market Industry. The National Institute of Diabetes and Digestive and Kidney Diseases reports that approximately 70 million people in the US suffer from digestive diseases, creating a robust demand for solutions like eubiotic products. As more individuals seek treatments to alleviate symptoms associated with these disorders, manufacturers are expanding their offerings to include a variety of eubiotic formulations.This ongoing trend is indicative of a growing market poised to support innovative products aimed at improving digestive health. **Expansion of the Functional Foods and Beverages Market** The functional foods and beverages sector in the US is experiencing remarkable growth, which is significantly contributing to the US Eubiotics Market Industry. According to the Food and Agriculture Organization, the market for functional foods is projected to reach USD 252 billion by 2027. This sector's expansion includes an increasing incorporation of eubiotic ingredients in various food and beverage products. Given the growing consumer inclination towards functional foods that offer health benefits beyond basic nutrition, manufacturers are responding by formulating products enriched with eubiotics.This growth reflects a larger tendency towards health-oriented market trends, bolstering eubiotic sales even further. **US Eubiotics Market Segment Insights** **Eubiotics Market Form Insights** The US Eubiotics Market encompasses various forms, primarily Liquid and Dry, designed to enhance gut health and overall well-being. With the market witnessing a significant growth trajectory, the Liquid form has gained traction due to its ease of consumption and rapid absorption in the digestive system, making it particularly appealing for both consumers and manufacturers. On the other hand, the Dry form, which includes powders and granules, often dominates due to its convenience in storage and shelf life. The growing awareness around the health benefits associated with eubiotics, such as improved digestive health and immune function, continues to drive demand across both forms.Additionally, increasing investments in Research and Development are expected to lead to innovations in formulations that cater to varying consumer preferences, including organic and non-GMO options. The regulatory environment in the US poses challenges as manufacturers must navigate complex compliance standards, yet it also presents opportunities for those who can effectively demonstrate efficacy and safety in their products. Consumers are increasingly leaning towards products with clear labeling and proven benefits, propelling market players to enhance transparency in their formulation processes.Trends indicate that both Liquid and Dry segments will coexist as significant contributors to overall market growth, driven by their unique attributes and consumers' evolving preferences. The focus remains on delivering tailored solutions that address specific health concerns, ensuring that the segments stay relevant and appealing in a competitive landscape. As such, the US Eubiotics Market is positioned for continued expansion, with both forms playing crucial roles in meeting growing consumer demands for health-oriented products. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Eubiotics Market Type Insights** The US Eubiotics Market, under the Type segment, encompasses a diverse range of products including Prebiotics, Probiotics, and Others, which play a pivotal role in promoting gut health and overall well-being. Prebiotics are crucial as they serve as food for beneficial gut bacteria, enhancing digestive function and potentially boosting immune responses. Probiotics, on the other hand, are live microorganisms that offer health benefits when consumed, leading to their growing popularity among consumers seeking natural health solutions. The 'Others' category includes various innovative ingredients that are gaining traction in the market due to the increasing demand for holistic health products.The market growth is driven by rising health consciousness among consumers, increasing awareness of the benefits of gut health, and a growing preference for natural and organic products. However, challenges such as regulatory hurdles and consumer skepticism regarding efficacy may hinder market expansion. Nevertheless, the potential for innovation and increasing investment in Research and Development present considerable opportunities within the US Eubiotics Market, reflecting a broad acceptance and integration of eubiotic products in daily dietary routines.As this market evolves, the segmentation will continue to adapt to consumer preferences, shaping the future landscape of health-oriented products. **Eubiotics Market Function Insights** The US Eubiotics Market is prominently characterized by its diverse Function categorization, addressing critical health aspects such as General Health and Wellness, Immunity, Gut and Digestive Health, and Others. Notably, the rising consumer awareness regarding holistic health and preventive care has encouraged a significant shift toward products that support overall well-being, which has seen a growing inclination towards Eubiotics. The Immunity segment is particularly relevant in the wake of heightened health consciousness following global health events, driving demand for products that can bolster immune functions effectively.Concurrently, Gut and Digestive Health stands out as a vital focus area, given the increasing prevalence of gastrointestinal disorders and the recognition of gut health’s pivotal role in overall physical health. Overall, these segments not only reflect evolving consumer preferences but also underline the potential for substantial expansion within the US Eubiotics Market. The market dynamics are greatly influenced by trends favoring natural ingredients, leading to vibrant growth opportunities in uncharted segments. The landscape is supported by regulatory frameworks advocating for health-promoting substances, creating a conducive environment for innovation and development in the Eubiotics industry. **Eubiotics Market Livestock Insights** The Livestock segment within the US Eubiotics Market encompasses various categories, including Aquatic, Poultry, Ruminants, Swine, and Others, each contributing to the overall market dynamics and growth. Poultry remains a significant part of this market, driven by its rapid production cycles and the increased demand for healthy meat options among consumers, leading to a strong focus on nutritional additives like eubiotics. Ruminants, such as cows and sheep, also play a crucial role, as they require specialized nutritional support to enhance digestion and maximize feed efficacy.In the Swine sector, eubiotics are vital in promoting gut health, thus improving growth rates and overall productivity, making this segment increasingly important for farmers focused on sustainability and efficiency. Aquatic species, while a smaller portion of the market, are gaining traction; advancements in eubiotics are crucial for enhancing fish growth and ensuring healthier aquaculture practices. The Others category includes diverse livestock types, further highlighting the versatility of eubiotics in improving animal welfare and performance across various species.Collectively, these sectors illustrate the US Eubiotics Market's revenue potential and opportunities for innovation as the demand for better livestock management practices continues to grow. **US Eubiotics Market Key Players and Competitive Insights** The US Eubiotics Market has witnessed substantial growth in recent years, driven by increasing consumer awareness regarding health and wellness, alongside rising demand for natural and organic products. Companies operating in this sector are turning towards innovative solutions that promote a healthy gut microbiome, both in humans and animals. The competitive landscape is characterized by a combination of established firms and emerging players, each striving to differentiate their offerings through product development, strategic partnerships, and effective marketing strategies. The market dynamics are further shaped by regulatory frameworks and consumer preferences that increasingly favor sustainable and environmentally friendly alternatives. With technological advancements and research-driven approaches, businesses are seeking novel ways to enhance their position within the eubiotics domain.Kemin Industries has established itself as a significant player in the US Eubiotics Market, leveraging its extensive research and development capabilities to produce high-quality products. The company has a robust portfolio of eubiotics solutions that cater to both animal health and human gut health. Their commitment to sustainability and quality is evident in their sourcing and manufacturing processes. Kemin Industries has built a strong brand reputation based on innovation and reliability, positioning itself to meet the diverse needs of its customers. The company's well-established distribution networks allow for widespread market presence, facilitating the efficient delivery of its products to various segments within the eubiotics sphere. The synergy between scientific research and practical applications in their offerings underlines Kemin's competitive advantage in the US market.Royal DSM boasts a formidable presence in the US Eubiotics Market, with a well-rounded suite of products aimed at improving gut health and optimizing overall well-being. The company is known for its specialty ingredients that cater to both the animal nutrition and human nutrition sectors. Royal DSM focuses on innovation and sustainability, further solidified through strategic mergers and acquisitions that expand its market reach and product offerings. Their commitment to research collaboration and product development enables them to effectively respond to emerging trends and consumer demands, positioning the company as a leader in the eubiotics space. Key products include probiotics, prebiotics, and other functional ingredients aimed at enhancing health outcomes. Royal DSM's strong emphasis on quality and effectiveness, coupled with comprehensive market presence, underscores its strengths in the competitive landscape of the US Eubiotics Market. **Key Companies in the US Eubiotics Market Include** - Kemin Industries - Royal DSM - BASF - Eligo Bioscience - Chr. Hansen - Alltech - Novozymes - Lallemand - Adisseo - Cargill - ProbioFerm - Phytobiotics - Nutreco - Behn Meyer - Synlogic **US Eubiotics Market Industry Developments** The US Eubiotics Market has recently witnessed significant developments, particularly with companies like Kemin Industries, Royal DSM, BASF, and Alltech expanding their portfolios to enhance gut health solutions. The market has been driven by increasing consumer demand for natural and organic products, alongside growing awareness of the health benefits associated with eubiotics. In terms of mergers and acquisitions, no recent publicly known transactions have been reported for the specified companies within the United States. However, the overall market valuation has grown, with estimates indicating a rising interest in functional foods and dietary supplements, enhancing the financial performance of leading companies such as Novozymes and Chr. Hansen. In addition, the US government has been promoting research initiatives to advance the integration of eubiotics in livestock and pet nutrition, effectively supporting sustainable agricultural practices in recent years, including considerable investments in agricultural bio-innovation programs. The market is anticipated to continue evolving as consumer preferences shift toward healthier lifestyle choices, fostering increased R&D investments from companies like Cargill and Adisseo to meet emerging demands. **US Eubiotics Market Segmentation Insights** **Eubiotics Market Form****Outlook** - Liquid - Dry **Eubiotics Market Type****Outlook** - Prebiotics - Probiotics - Others **Eubiotics Market Function****Outlook** - General Health & Wellness - Immunity - Gut & Digestive Health - Others **Eubiotics Market Livestock****Outlook** - Aquatic - Poultry - Ruminants - Swine - Others ## Market Drivers ### Rising Awareness of Gut Health The increasing awareness of gut health among consumers is a pivotal driver for the US eubiotics market. As individuals become more informed about the connection between gut microbiota and overall health, there is a growing demand for products that support digestive wellness. This trend is reflected in market data, which indicates that the eubiotics segment is projected to grow at a compound annual growth rate of approximately 8% over the next five years. Consumers are actively seeking natural solutions, leading to a surge in the availability of eubiotic products in health food stores and online platforms. This heightened focus on gut health is likely to propel the US eubiotics market forward, as manufacturers innovate to meet consumer preferences for effective and natural formulations. ### Growing Demand for Functional Foods The demand for functional foods in the US eubiotics market is on the rise, driven by consumers seeking products that offer health benefits beyond basic nutrition. Functional foods, which often incorporate eubiotics, are perceived as a proactive approach to health management. Market analysis indicates that the functional food segment is expected to reach a valuation of over $300 billion by 2027, with eubiotics playing a crucial role in this growth. As consumers increasingly prioritize health and wellness, the integration of eubiotics into everyday food products is likely to expand, further solidifying the position of the US eubiotics market as a key player in the health food sector. ### Shift Towards Preventive Healthcare The shift towards preventive healthcare is reshaping consumer behavior and driving the US eubiotics market. As healthcare costs continue to rise, individuals are increasingly seeking preventive measures to maintain their health and well-being. Eubiotics, known for their potential to enhance gut health and boost immunity, are becoming integral to this preventive approach. Market data suggests that the preventive healthcare market is projected to grow significantly, with eubiotics positioned as a key component of this trend. This shift not only reflects changing consumer attitudes but also presents opportunities for manufacturers to develop targeted eubiotic products that align with the preventive healthcare paradigm, thereby propelling the US eubiotics market forward. ### Regulatory Support for Eubiotic Products Regulatory support for eubiotic products is a critical driver influencing the US eubiotics market. The US Food and Drug Administration (FDA) has established guidelines that facilitate the approval and commercialization of eubiotic ingredients, thereby encouraging innovation and market entry. This regulatory framework not only ensures product safety but also enhances consumer confidence in eubiotic solutions. As regulations evolve to accommodate the growing interest in gut health, companies are likely to benefit from streamlined processes for bringing new eubiotic products to market. This supportive regulatory environment is expected to foster growth within the US eubiotics market, as businesses capitalize on the opportunities presented by favorable policies. ### Increased Investment in Research and Development Investment in research and development (R&D) within the US eubiotics market is another significant driver. Companies are increasingly allocating resources to explore the potential benefits of various eubiotic strains and their applications in health and nutrition. This focus on R&D is expected to yield innovative products that cater to specific health concerns, such as obesity, diabetes, and immune support. According to industry reports, R&D spending in the eubiotics sector has seen a notable increase, with projections suggesting a rise of 15% annually. This investment not only enhances product efficacy but also fosters consumer trust in eubiotic solutions, thereby stimulating market growth. ## Future Outlook The US [eubiotics](https://www.marketresearchfuture.com/reports/eubiotics-market-5007) market is projected to grow at a 6.62% CAGR from 2025 to 2035, driven by increasing consumer awareness and demand for health-focused products. **New opportunities:** - Development of targeted eubiotic formulations for specific health conditions. - Expansion into online retail channels to enhance market reach. - Partnerships with health professionals for product endorsements and education. By 2035, the US eubiotics market is expected to be robust, reflecting strong growth and innovation. ## Segment Insights ### By Application: Animal Feed (Largest) vs. Human Nutrition (Fastest-Growing) In the US eubiotics market, the application segment showcases a diverse distribution of market shares across various sectors. The largest segment, Animal Feed, significantly dominates the market due to its critical role in livestock health and productivity. Human Nutrition follows closely, capturing a considerable share as consumers become increasingly aware of gut health and the benefits of eubiotics. Pharmaceuticals and Cosmetics represent smaller yet essential segments in this market, contributing to the overall growth and diversification of eubiotics applications. Animal Feed (Dominant) vs. Human Nutrition (Emerging) Animal Feed stands as the dominant application segment in the US eubiotics market, driven by increasing livestock production and a growing emphasis on animal welfare and health. This segment benefits from innovations in feed formulations that enhance performance and gut health among animals. In contrast, Human Nutrition is an emerging segment, rapidly gaining traction as more consumers seek natural supplements to boost their health. The rising focus on preventive healthcare and holistic wellness drives this trend, supported by research linking eubiotics to improved metabolic health and immunity. ### By Type: Probiotics (Largest) vs. Prebiotics (Fastest-Growing) In the US eubiotics market, [probiotics](https://www.marketresearchfuture.com/reports/probiotics-market-966) hold the largest market share, representing a substantial portion of consumer preference due to their established benefits for gut health, immunity, and overall well-being. Prebiotics, while smaller in share, are quickly gaining traction as consumers become more aware of their role in enhancing the effectiveness of probiotics by feeding beneficial gut bacteria. This dynamic market distribution highlights the stronghold of probiotics while also acknowledging the growing interest in prebiotics for optimized gut health. Probiotics (Dominant) vs. Prebiotics (Emerging) Probiotics are the dominant segment within the US eubiotics market, celebrated for their extensive research-backed health benefits, including digestive health, immune support, and potential mental health improvements. They are commonly found in various products, from yogurts to dietary supplements, appealing to a broad consumer base. In contrast, prebiotics are emerging as an exciting category, recognized for their ability to enhance gut flora by providing nourishment to beneficial bacteria. This segment is witnessing increased innovation and product development, as health-conscious consumers seek holistic approaches to wellness, further driving the demand for prebiotic products in the marketplace. ### By Form: Powder (Largest) vs. Liquid (Fastest-Growing) In the US eubiotics market, the form segment reveals a diverse distribution among powder, liquid, capsules, and tablets. Currently, powder emerges as the largest segment, capturing significant market share due to its versatility and easy incorporation into various formulations. This growth is supported by a broad range of applications, from animal feed to health supplements, catering to a wide audience and enhancing its appeal across multiple sectors. On the other hand, the liquid form is gaining traction, rapidly evolving as a convenient and effective solution for consumers seeking immediate bioavailability and enhanced absorption rates. Form: Powder (Dominant) vs. Liquid (Emerging) Powdered eubiotics dominate the form segment, primarily due to their extensive application in animal nutrition and functional food products. Their versatility allows for easy mixing and formulation, making them the preferred choice for many manufacturers. In contrast, the liquid form is emerging as a popular choice, particularly among health-conscious consumers seeking efficacy and convenience. Liquid eubiotics offer higher bioavailability and may present a faster option for absorption, tapping into a growing market of functional beverages and supplements. As consumers increasingly seek out effective and easily consumable forms of nutrition, both segments are expected to evolve dynamically, driving market growth in distinct yet complementary ways. ### By Distribution Channel: Online (Largest) vs. Pharmacies (Fastest-Growing) In the US eubiotics market, the distribution channel landscape shows a notable preference for online platforms, which has emerged as the largest segment. This channel benefits from increasing digital penetration, convenience, and the growing trend of consumers preferring to purchase health-related products online. On the other hand, pharmacies have surfaced as the fastest-growing segment, attributed to an increasing number of consumers seeking professional advice and recommendations from healthcare providers when purchasing eubiotic products. Online (Dominant) vs. Pharmacies (Emerging) Online channels have established themselves as the dominant distribution route in the US eubiotics market, driven by ease of access, a wide variety of product options, and the consumer shift toward digital purchasing habits. Eubiotics sold online often benefit from competitive pricing and extensive customer reviews, enhancing consumer trust. In contrast, pharmacies represent an emerging distribution channel, attracting customers who prefer direct interaction with healthcare professionals. The growth of pharmacies in this market is propelled by a broader acceptance of eubiotics among healthcare providers, as well as increased consumer awareness of gut health and its importance to overall well-being, highlighting the integral role of pharmacies in educating and serving consumers. ## Competitive Benchmarking The US eubiotics market is characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding health and wellness, alongside a growing demand for natural and organic products. Key players such as BASF SE (DE), DuPont de Nemours Inc (US), and Kemin Industries Inc (US) are strategically positioned to leverage these trends. BASF SE (DE) focuses on innovation in product development, particularly in the area of probiotics and [prebiotics](https://www.marketresearchfuture.com/reports/prebiotics-market-1893), while DuPont de Nemours Inc (US) emphasizes partnerships with local producers to enhance its supply chain and product offerings. Kemin Industries Inc (US) is actively pursuing digital transformation initiatives to optimize its operations and improve customer engagement, collectively shaping a competitive environment that prioritizes innovation and responsiveness to market demands. The business tactics employed by these companies include localizing manufacturing to reduce lead times and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure fosters an environment where innovation and strategic partnerships are critical for success, as companies seek to differentiate themselves in a crowded marketplace. In November 2025, Kemin Industries Inc (US) announced the launch of a new line of eubiotic products aimed at enhancing gut health in livestock. This strategic move is significant as it not only expands Kemin's product portfolio but also aligns with the growing trend towards sustainable animal husbandry practices. By focusing on gut health, Kemin positions itself as a leader in the eubiotics space, catering to the increasing demand for natural solutions in animal nutrition. In December 2025, DuPont de Nemours Inc (US) entered into a strategic partnership with a leading agricultural cooperative to enhance its distribution network for eubiotic products. This collaboration is likely to strengthen DuPont's market presence and improve access to its innovative solutions, thereby enhancing its competitive edge. The partnership reflects a broader trend in the industry where companies are seeking to leverage local networks to optimize their supply chains and reach a wider customer base. In January 2026, BASF SE (DE) unveiled a new research initiative focused on the development of sustainable eubiotic solutions. This initiative underscores BASF's commitment to sustainability and innovation, as it seeks to address the growing consumer demand for environmentally friendly products. The emphasis on sustainability is becoming increasingly important in the eubiotics market, as companies recognize the need to align their strategies with consumer values. As of January 2026, current competitive trends in the eubiotics market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a pivotal role in shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a marked shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize these aspects will likely emerge as leaders in the eubiotics market. ## Recent News & Developments The US Eubiotics Market has recently witnessed significant developments, particularly with companies like Kemin Industries, Royal DSM, BASF, and Alltech expanding their portfolios to enhance gut health solutions. The market has been driven by increasing consumer demand for natural and organic products, alongside growing awareness of the health benefits associated with eubiotics. In terms of mergers and acquisitions, no recent publicly known transactions have been reported for the specified companies within the United States. However, the overall market valuation has grown, with estimates indicating a rising interest in functional foods and dietary supplements, enhancing the financial performance of leading companies such as Novozymes and Chr. Hansen. In addition, the US government has been promoting research initiatives to advance the integration of eubiotics in [livestock](https://www.marketresearchfuture.com/reports/livestock-market-59927) and pet nutrition, effectively supporting sustainable agricultural practices in recent years, including considerable investments in agricultural bio-innovation programs. The market is anticipated to continue evolving as consumer preferences shift toward healthier lifestyle choices, fostering increased R&D investments from companies like Cargill and Adisseo to meet emerging demands. ## Report Scope | MARKET SIZE 2024 | 1.05(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 1.13(USD Billion) | | MARKET SIZE 2035 | 2.12(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.62% (2024 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | BASF SE (DE), DuPont de Nemours Inc (US), Chr. Hansen Holding A/S (DK), Evonik Industries AG (DE), Kemin Industries Inc (US), Novozymes A/S (DK), Lallemand Inc (CA), Alltech Inc (US), BioCare Copenhagen A/S (DK) | | Segments Covered | Application, Type, Form, Distribution Channel | | Key Market Opportunities | Growing consumer demand for gut health products drives innovation in the us eubiotics market. | | Key Market Dynamics | Rising consumer demand for gut health products drives innovation and competition in the US eubiotics market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US eubiotics market as of 2024?** A: The US eubiotics market was valued at 1.05 USD Billion in 2024. **Q: What is the projected market valuation for the US eubiotics market in 2035?** A: The market is projected to reach 2.12 USD Billion by 2035. **Q: What is the expected CAGR for the US eubiotics market during the forecast period 2025 - 2035?** A: The expected CAGR for the US eubiotics market during 2025 - 2035 is 6.62%. **Q: Which companies are considered key players in the US eubiotics market?** A: Key players include BASF SE, DuPont de Nemours Inc, Chr. Hansen Holding A/S, and others. **Q: What are the main application segments of the US eubiotics market?** A: The main application segments include Animal Feed, Human Nutrition, Pharmaceuticals, and Cosmetics. **Q: How did the Animal Feed segment perform in terms of valuation from 2024 to 2035?** A: The Animal Feed segment is expected to grow from 0.45 USD Billion in 2024 to 0.9 USD Billion by 2035. **Q: What types of eubiotics are included in the market analysis?** A: The market analysis includes Probiotics, Prebiotics, Postbiotics, and Synbiotics. **Q: What is the projected growth for the Probiotics segment by 2035?** A: The Probiotics segment is projected to grow from 0.42 USD Billion in 2024 to 0.84 USD Billion by 2035. **Q: What distribution channels are utilized in the US eubiotics market?** A: Distribution channels include Online, Offline, Pharmacies, and Health Stores. **Q: How is the market for eubiotics expected to evolve in terms of product forms by 2035?** A: The market for product forms such as Powder, Liquid, Capsules, and Tablets is expected to grow significantly by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-eubiotics-market-14242*